Targeted Therapies for Pancreatic Cancer
Pancreatic cancer is the third leading cause of cancer related death and by 2030, it will be second only to lung cancer. We have seen tremendous advances in therapies for lung cancer as well as other solid tumors using a molecular targeted approach but our progress in treating pancreatic cancer has...
Main Authors: | Idoroenyi Amanam, Vincent Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/2/36 |
Similar Items
-
Pancreatic metastases from renal cancer: comparing surgery and pharmacotherapy efficacy
by: A. G. Kotelnikov, et al.
Published: (2020-01-01) -
Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer
by: Leticia Moreira, et al.
Published: (2018-01-01) -
Definition of Personalized Medicine and Targeted Therapies: Does Medical Familiarity Matter?
by: Valentyn Fournier, et al.
Published: (2021-01-01) -
Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer
by: Santosh Renuse, et al.
Published: (2021-07-01) - Noncoding RNAs as novel pancreatic cancer targets